Phenols
Cambridge Isotope Laboratories 1 2 3 7 8-PentaCDF (unlabeled) 25 ng/mL in nonane 0 1 mL
1 2 3 7 8-PentaCDF (unlabeled) 25 ng/mL in nonane 0 1 mL
Apexbio Technology LLC Piperacillin Sodium 59703-84-3 10mM (in 1mL DMSO)
Piperacillin Sodium (CAS 59703-84-3) is a small-molecule inhibitor targeting bacterial penicillin-binding proteins (PBPs) It is designed to inhibit cell wall biosynthesis thereby disrupting peptidoglycan cross-linking in bacteria Piperacillin Sodium exerts its biological activity primarily through irreversible binding to bacterial transpeptidases (PBPs) In in vitro studies Piperacillin Sodium demonstrates antibacterial inhibition with IC50 values typically ranging from 2 to 16 g/ml depending on microorganism sensitivity and experimental conditions Based on these pharmacological properties Piperacillin Sodium holds research potential in microbiological studies and the investigation of Pseudomonas aeruginosa infections
eMolecules 683239-16-9 | 20-(tert-Butoxy)-20-oxoicosanoic acid | ChemScene | MFCD23136041 | 398.628 | C24H46O4 | 97.000 | CC(C)(C)OC(=O)CCCCCCCCCCCCCCCCCCC(O)=O | 5g | 536799752
20-(tert-Butoxy)-20-oxoicosanoic acid | ChemScene | 683239-16-9 | MFCD23136041 | 398.628 | C24H46O4 | 97.000 | CC(C)(C)OC(=O)CCCCCCCCCCCCCCCCCCC(O)=O | 5g | 536799752
Cambridge Isotope Laboratories 2 4-Dichlorophenol (ring-D3 98%) 0 5 g
2 4-Dichlorophenol (ring-D3 98%) 0 5 g
Accela Chembio Inc 4-hydroxy-3-methylbenzoic Acid | 25g | 499-76-3 | MFCD00270105 | 97+% | Shelf Life: 1440 Days | Regular
4-hydroxy-3-methylbenzoic Acid | 25g | 499-76-3 | MFCD00270105 | 97+% | Shelf Life: 1440 Days | Regular
Apexbio Technology LLC ADL5859 HCl 850173-95-4 10mM (in 1mL DMSO)
ADL5859 HCl (CAS 850173-95-4) is a potent selective agonist of the -opioid receptor exhibiting sub-nanomolar affinity and strong receptor selectivity In vitro studies have demonstrated that ADL5859 possesses robust -opioid agonist activity with minimal inhibition of the hERG channel In rat models of inflammatory mechanical allodynia oral administration of ADL5859 effectively reversed hypersensitivity with an ED50 of 1 4 mg/kg Its antiallodynic effects are antagonized by -opioid receptor antagonists confirming receptor specificity ADL5859 is under investigation as a candidate for the treatment of various pain conditions
Cambridge Isotope Laboratories Bisphenol F (D10 98%) 100 ug/mL in methanol-OD 1 2 mL
Bisphenol F (D10 98%) 100 ug/mL in methanol-OD 1 2 mL
Cambridge Isotope Laboratories Microcystin-LR ethylated (D5 98%) 0 025 mg
Microcystin-LR ethylated (D5 98%) 0 025 mg
Apexbio Technology LLC Milnacipran HCl 101152-94-7 10mM (in 1mL DMSO)
Milnacipran hydrochloride (CAS 101152-94-7) is a small molecule classified as a serotonin-norepinephrine reuptake inhibitor (SNRI) It acts by selectively inhibiting the reuptake of both serotonin and norepinephrine in the central nervous system thereby modulating synaptic neurotransmitter levels Milnacipran HCl has been investigated for its ability to influence neurochemical pathways implicated in pain processing and mood regulation It is utilized in biomedical research to study the pathophysiology of fibromyalgia and related disorders involving monoaminergic dysfunction
Apexbio Technology LLC NPS-1034 1221713-92-3 50mg
NPS-1034 (CAS 1221713-92-3) is a potent inhibitor of the receptor tyrosine kinase MET with an IC50 of 4 nmol/L MET activated by hepatocyte growth factor is implicated in morphogenesis and tumor progression across various cancers NPS-1034 suppresses cell viability in MET-overexpressing and phosphorylated MET-positive cell lines such as MKN45 and SNU638 with IC50 values of 112 7 nmol/L and 190 3 nmol/L respectively In vivo oral administration of NPS-1034 reduces tumor growth and angiogenesis in MKN45 xenograft models These characteristics support the utility of NPS-1034 in studying MET-driven oncogenic signaling and its therapeutic targeting